{"id":"W4406149118","doi":"10.1016/j.oooo.2024.10.096","title":"Iscalimab (CFZ533) in patients with Sjögren disease: week 24 efficacy and safety results of a randomized, placebo-controlled, phase 2b dose-ranging study","year":2025,"lang":"en","type":"article","venue":"Oral Surgery Oral Medicine Oral Pathology and Oral Radiology","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Dose-ranging study; Placebo; Randomized controlled trial; Phases of clinical research; Safety profile; Phase (matter); Dermatology; Internal medicine; Adverse effect; Double blind; Clinical trial; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002722815,0.0005350676,0.003991009,0.0009061321,0.0001956114,0.00001080314,0.0001072115,0.0002779963,0.0001039577],"category_scores_gemma":[0.002621012,0.0003327194,0.0002030427,0.0007022176,0.001555815,0.0001389376,0.00009779897,0.0005129508,0.000002741787],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004455389,"about_ca_system_score_gemma":0.0001781732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003962531,"about_ca_topic_score_gemma":0.0001952476,"domain_scores_codex":[0.9951628,0.001530195,0.001520603,0.0008555506,0.000271336,0.0006595468],"domain_scores_gemma":[0.9963119,0.002377425,0.0003737347,0.0004327375,0.000170158,0.0003340683],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5328078,0.001766722,0.4546753,0.00007581657,0.0003348919,0.0005000746,0.0002926312,0.00001075651,0.00001225451,0.0001103419,0.001711788,0.007701682],"study_design_scores_gemma":[0.5882879,0.003720007,0.404609,0.0002995353,0.001452181,0.00007486478,0.0003783123,0.0002260636,0.00000166823,0.0002971527,0.0003853129,0.0002679535],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873647,0.003388886,0.0002277543,0.004720662,0.0007017275,0.003135258,0.00006703348,0.00006770876,0.000326233],"genre_scores_gemma":[0.9974163,0.0003781549,0.0001797606,0.001023447,0.00008174909,0.0001536473,0.0003716443,0.00002995869,0.0003653125],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05548023,"threshold_uncertainty_score":0.9999125,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01631337186782924,"score_gpt":0.2865686407360584,"score_spread":0.2702552688682292,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}